Perineze Triple Dye
NDC 55739-1022
Product Information
Perineze Triple Dye is a OTC MONOGRAPH NOT FINAL-approved product labeled by Peace Medical Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 55739-1022 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 55739-1022?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BRILLIANT GREEN (UNII: G0L543D370)
- BRILLIANT GREEN (UNII: G0L543D370) (Active Moiety)
- PROFLAVINE HEMISULFATE (UNII: 27V8M747VB)
- PROFLAVINE HEMISULFATE (UNII: 27V8M747VB) (Active Moiety)
- GENTIAN VIOLET (UNII: J4Z741D6O5)
- GENTIAN VIOLET (UNII: J4Z741D6O5) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1188515 - brilliant green 2.29 MG / proflavine 1.14 MG / gentian violet 2.29 MG in 0.61 mL Topical Solution
- RxCUI: 1188515 - brilliant green 3.75 MG/ML / gentian violet 3.75 MG/ML / proflavine 1.87 MG/ML Topical Solution
- RxCUI: 1188520 - Perineze Triple Dye 2.29 MG / 1.14 MG / 2.29 MG in 0.61 mL Topical Solution
- RxCUI: 1188520 - brilliant green 3.75 MG/ML / gentian violet 3.75 MG/ML / proflavine 1.87 MG/ML Topical Solution [Perineze Triple Dye]
- RxCUI: 1188520 - Perineze Triple Dye (brilliant green 3.75 MG/ML / gentian violet 3.75 MG/ML / proflavine 1.87 MG/ML) Topical Solution
* Please review the full disclaimer at the bottom of this page.